TITLE

That is why I stopped the ART: patients' & providers' perspectives on barriers to and enablers of HIV treatment adherence in a South African workplace programme

AUTHOR(S)
Dahab, Mison; Charalambous, Salome; Hamilton, Robin; Fielding, Katherine; Kielmann, Karina; Churchyard, Gavin J.; Grant, Alison D.
PUB. DATE
January 2008
SOURCE
BMC Public Health;2008, Vol. 8 Issue 1, p63
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: As ART programmes in African settings expand beyond the pilot stages, adherence to treatment may become an increasing challenge. This qualitative study examines potential barriers to, and facilitators of, adherence to ART in a workplace programme in South Africa. Methods: We conducted key informant interviews with 12 participants: six ART patients, five health service providers (HSPs) and one human resources manager. Results: The main reported barriers were denial of existence of HIV or of one's own positive status, use of traditional medicines, speaking a different language from the HSP, alcohol use, being away from home, perceived severity of side-effects, feeling better on treatment and long waiting times at the clinic. The key facilitators were social support, belief in the value of treatment, belief in the importance of one's own life to the survival of one's family, and the ability to fit ART into daily life schedules. Conclusion: Given the reported uncertainty about the existence of HIV disease and the use of traditional medicines while on ART, despite a programme emphasising ART counselling, there is a need to find effective ways to support adherence to ART even if the individual does not accept biomedical concepts of HIV disease or decides to use traditional medicines. Additionally, providers should identify ways to minimize barriers in communication with patients with whom they have no common language. Finally, dissatisfaction with clinical services, due to long waiting times, should be addressed.
ACCESSION #
51488239

 

Related Articles

  • Drug for testing HIV wasting gets early approval.  // FDA Consumer;Nov96, Vol. 30 Issue 9, p2 

    Introduces the injectable drug Serostim approved by Food and Drug Administration (FDA) to treat wasting in people with Human Immunodeficiency Virus (HIV) infection. Signs and symptoms of patients with HIV infection; Effects of Serostim drug to patients.

  • Screening Alternative Therapies for HIV. Reeves, Cherie; Calabrese, Carlo; Standish, Leanna J.; Bain, Shoshanah // AIDS Patient Care & STDs;Feb1998, Vol. 12 Issue 2, p87 

    Focuses on the screening of alternative medicine for effectiveness in human immunodeficiency virus (HIV) disease which is the mission of the Bastyr University AIDS Research Center. Definition of alternative medicine; Information on the observational study implemented by the center to address...

  • The use of alternative therapies for HIV infection: Implications for patient care. Carwein, Vicky L.; Sabo, Carolyn E. // AIDS Patient Care & STDs;Apr97, Vol. 11 Issue 2, p79 

    Describes patterns of usage of alternative therapies by HIV-infected people. Most commonly used alternative therapies; Issues related to patient care.

  • Host genes and HIV: The role of the chemokine receptor gene CCR5 and its allele (...32 CCR5). McNicholl, Janet M.; Smith, Dawn K. // Emerging Infectious Diseases;Jul-Sep97, Vol. 3 Issue 3, p261 

    Describes the role of allelic susceptibility to and disease course of human immunodeficiency virus (HIV) infection. Number of persons who have died of AIDS in the late 1970s; How studies of the effect of host genes on susceptibility to HIV infection were facilitated; Details on chemokine...

  • Alternative therapy.  // Presidents & Prime Ministers;Mar/Apr98, Vol. 7 Issue 2, p33 

    Reports that an international study found that an effective alternative to the year-long regimen prescribed for persons co-infected with human immuno-deficiency virus (HIV) and tuberculosis (TB), is a two-month course of therapy to prevent active TB. Health organizations and centers who...

  • Naturopathy Lifestyle Intervention: A New Dimension in HIV Care. Arankalle, Dhananjay V.; Joseph, Babu // Journal of Alternative & Complementary Medicine;May2013, Vol. 19 Issue 5, p480 

    The author discusses information on a "health home" established by the National Institute of Naturopathy in Pune for human immunodeficiency virus (HIV)-positive individuals. It discusses asymptomatic clinical care provided to a 40-year-old woman who underwent naturopathic lifestyle intervention...

  • Rx: Antidote for HIV? Gallagher, John // Advocate;11/11/97, Issue 746, p45 

    States that antiviral drugs have proved effective in knocking out human immunodeficiency virus after infection, but it is prescribed only to health care workers. Postexposure prophylaxis (PEP) as an HIV treatment; Role of economics in determining the availability of PEP; Results from an HIV...

  • Detoxification Center-Based Sampling Missed a Subgroup of Higher Risk Drug Users, a Case from Guangdong, China. Peng Lin; Man Wang; Yan Li; Qiaoli Zhang; Fang Yang; Jinkou Zhao // PLoS ONE;Apr2012, Vol. 7 Issue 4, p1 

    Background: Injection drug use remains among the most important HIV transmission risk in China. Representativeness of drug users sampled from detoxification centers is questionable. A respondent driven sampling survey was conducted to compare the results with those from the detoxification center...

  • News @ a glance. Kondro, Wayne // CMAJ: Canadian Medical Association Journal;5/6/2008, Vol. 178 Issue 10, p1268 

    The article offers two health-related news briefs in Canada. The British Columbia has become the first province to include acupuncture as a supplementary benefit under its health insurance plan. A report by the government of Manitoba indicates that HIV infection is spreading more rapidly in...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics